HEALTH OF WOMAN.2017.1(117):56–61

Pustotina O. A., Akhmedova A. E.
KM–clinic, Moskow
Published: «Effektivnaya pharmacoterapiya. Akusherstvo i gynecologiya» No.3(35)/2014

REFERENCES

1. Pietrzik K, Bailey L, Shane B. 2010. Folic acid and L-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics. Clin. Pharmacokinet. 49;8:535–548. https://doi.org/10.2165/11532990-000000000-00000; PMid:20608755

2. Lucock M. 2000. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol. Genet. Metab. 71;1–2:121–138. https://doi.org/10.1006/mgme.2000.3027; PMid:11001804

3. Cunningham F, Leveno K, Bloom S et al. 2009. Williams Obstetrics. 23rd ed. New York: McGraw-Hill.

4. Crider KS, Yang TP, Berry RJ et al. 2012. Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate’s role. Adv. Nutr. 3;1:21–38. https://doi.org/10.3945/an.111.000992; PMid:22332098 PMCid:PMC3262611

5. Müller  T, Jugel C, Muhlack S et al. 2013. Methyl group-donating vitamins elevate 3-O-methyldopa in patients with Parkinson disease. Clin. Neuropharmacol. 36;2:52–54. https://doi.org/10.1097/WNF.0b013e318283fa18; PMid:23503547

6. Smith AD, Kim YI, Refsum H. 2008. Is folic acid food for everyone? Am. J. Clin. Nutr. 87;3:517–533. PMid:18326588

7. Kidd PM. 2008. Alzheimer’s disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention. Altern. Med. Rev. 13;2:85–115. PMid:18590347

8. Vogel S, Meyer K, Fredriksen A et al. 2013. Serum folate and vitamin B12 concentrations in relation to prostate cancer risk: a Norwegian population-based nested case-control study of 3000 cases and 3000 controls within the JANUS cohort. Int. J. Epidemiol. 42;1:201–210. https://doi.org/10.1093/ije/dys199; PMid:23508410

9. Duthie SJ. 2011. Folat and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis. J. Inherit. Metab. Dis. 34;1:101–109. https://doi.org/10.1007/s10545-010-9128-0; PMid:20544289

10. Yang IV, Schwartz DA. 2012. Epigenetic mechanisms and the development of asthma. J. Allergy Clin. Immunol. 130;6:1243–1255. https://doi.org/10.1016/j.jaci.2012.07.052; PMid:23026498 PMCid:PMC3518374

11. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991. 338;8760:131–137. https://doi.org/10.1016/0140-6736(91)90133-A

12. Ptikin RM. 2007. Folate and neural tube defects. Am. J. Clin. Nutr. 85;1:285–288.

13. De Wals P, Tairou F, Van Allen MI et al. 2007. Reduction in neural-tube defects after folic acid fortification in Canada. N. Engl. J. Med. 357;2:135–142. https://doi.org/10.1056/NEJMoa067103; PMid:17625125

14. Beaudin AE, Stover PJ. 2007. Folate-mediated one-carbon metabolism and neural tube defects: balancing genome synthesis and gene expression. Birth Defects Res. C. Embryo Today. 81;3:183–203. https://doi.org/10.1002/bdrc.20100; PMid:17963270

15. Greenberg JA, Bell SJ, Guan Y et al. 2011. Folic acid supplementaion and pregnancy: more than just neural tube defect prevention. Rev. Obstet. Gynecol. 4;2:52–59. PMid:22102928 PMCid:PMC3218540

16. Lumley J, Watson L, Watson M et al. 2011. WITHDRAWN: periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst. Rev. Vol. 4. ID CD001056.

17. Blencowe H, Cousens S, Modell B et al. 2010. Folic acid to reduce neonatal mortality from neural tube disorders. Int. J. Epidemiol. 39;Suppl. 1:110–121. https://doi.org/10.1093/ije/dyq028; PMid:20348114 PMCid:PMC2845867

18. Bentley S, Hermes A, Phillips D et al. 2011. Comparative effectiveness of a prenatal medical food to prenatal vitamins on hemoglobin levels and adverse outcomes: a retrospective analysis. Clin. Ther. 33;2:204–210. https://doi.org/10.1016/j.clinthera.2011.02.010; PMid:21440300

19. Van Beynum IM, Kapusta L, Bakker MK et al. 2010. Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registry-based case-control study in the northern Netherlands. Eur. Heart J. 31;4:464–471. https://doi.org/10.1093/eurheartj/ehp479; PMid:19952004

20. Czeizel AE, Puho EH, Langmar Z et al. 2010. Possible association of folic acid supplementation during pregnancy with reduction of preterm birth: a population-based study. Eur. J. Obstet. Gynecol. Reprod. Biol. 148;2:135–140. https://doi.org/10.1016/j.ejogrb.2009.10.016; PMid:19926391

21. Daly LE, Kirke PN, Molloy A et al. 1995. Folate levels and neural tube defects: implications for prevention. JAMA. 274;21:1698–1702. https://doi.org/10.1001/jama.1995.03530210052030; https://doi.org/10.1001/jama.274.21.1698

22. Fekete K, Berti C, Trovato M et al. 2012. Effect of folate intake on health outcomes in pregnancy: a systematic review and meta-analysis on birth weight, placental weight and length of gestation. Nutr. J. 11:75–86. https://doi.org/10.1186/1475-2891-11-75; PMid:22992251 PMCid:PMC3499376

23. Williams PJ, Bulmer JN, Innes BA et al. 2011. Possible roles for folic acid in the regulation of trophoblast invasion and placental development in normal early human pregnancy. Biol. Reprod. 84;6:1148–1153. https://doi.org/10.1095/biolreprod.110.088351; PMid:21349824

24. Salerno P, Bianchi F, Pierini A et al. 2008. Folic acid and congenital malformation: scientific evidence and public health strategies. Ann. Ig. 20;6:519–530. PMid:19238877

25. Kim MW, Hong SC, Choi JS et al. 2012. Homocysteine, folate and pregnancy outcomes. J. Obstet. Gynaecol. 32;6:520–524. https://doi.org/10.3109/01443615.2012.693984; PMid:22779952

26. Bodnar LM, Himes KP, Venkataramanan R et al. 2010. Maternal serum folate species in earlypregnancy and risk of preterm birth. Am. J. Clin. Nutr. 92;4:864–871. https://doi.org/10.3945/ajcn.2010.29675; PMid:20739422 PMCid:PMC2937585

27. Bailey LB, Berry R. 2005. Folic acid supplementation and the occurrence of congenital heart defects, orofacial clefts, multiple births, and miscarriage. Am. J. Clin. Nutr. 81;5:1213–1217.

28. Puri M, Kaur L, Walia GK et al. 2013. MTHFR C677T polymorphism, folate, vitamin B12 and homocysteine in recurrent pregnancy losses: a case control study among North Indian women. J. Perinat. Med. 41;5:549–554. https://doi.org/10.1515/jpm-2012-0252

29. Micle O, Muresan M, Antal L et al. 2012. The influence of homocysteine and oxidative stress on pregnancy outcome. J. Med. Life. 5;1:68–73. PMid:22574089 PMCid:PMC3307082

30. Takimoto H, Mito N, Umegaki K et al. 2007. Relationship between dietary folate intakes, maternal plasma total homocysteine and B-vitamins during pregnancy and fetal growth in Japan. Eur. J. Nutr. 46;5:300–306. https://doi.org/10.1007/s00394-007-0667-6; PMid:17623226

31. Szegedi SS, Castro CC, Koutmos M et al. 2008. Betaine-homocysteine S-methyltransferase-2 is an S-methylmethionine-homocysteine methyltransferase. J. Biol. Chem. 283;14:8939–8945. https://doi.org/10.1074/jbc.M710449200; PMid:18230605 PMCid:PMC2276374

32. Vollset SE, Refsum H, Tverdal A et al. 2001. Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study. Am. J. Clin. Nutr. 74;1:130–136. PMid:11451728

33. Vollset SE, Refsum H, Irgens LM et al. 2000. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. Am. J. Clin. Nutr. 71;4:962–968. https://doi.org/10.1097/00006254-200010000-00002

34. Xiao Y, Zhang Y, Wang M et al. 2013. Plasma S-adenosylhomocysteine is associated with the risk of cardiovascular events in patients undergoing coronary angiography: a cohort study. Am. J. Clin. Nutr. 98;5:1162–1169. https://doi.org/10.3945/ajcn.113.058727; PMid:24004894

35. Naess IA, Christiansen SC, Romundstad PR et al. 2008. Prospective study of homocysteine and MTHFR 677TT genotype and risk for venous thrombosis in a general population: results from the HUNT 2 study. Br. J. Haematol. 141;4:529–535. https://doi.org/10.1111/j.1365-2141.2008.07073.x; PMid:18318759

36. Potter K. 2008. Homocysteine and cardiovascular disease: should we treat? Clin. Biochem. Rev. 29;1:27–30. PMid:18566666 PMCid:PMC2423315

37. Wong Y, Almenda OP, McCaul KA et al. 2013. Homocysteine, frailty, and all-cause mortality in older men: the health in men study. J. Gerontol. A. Biol. Sci. Med. Sci. 68;5:590–598. https://doi.org/10.1093/gerona/gls211; PMid:23070880

38. Virtanen JK, Voutilainen S, Alfthan G. 2005. Homocysteine as a risk factor for CVD mortality in men with other CVD risk factors: the Kuopio Ischaemic Heart Disease Risk Factors (KIHD) Study. J. Intern. Med. 257;3:255–262. https://doi.org/10.1111/j.1365-2796.2005.01450.x; PMid:15715682

39. Hogeveen M, Blom HJ, den Heijer M. 2012. Maternal homocysteine and small-for-gestational-age offspring: systematic review and meta-analysis. Am. J. Clin. Nutr. 95;1:130–136. https://doi.org/10.3945/ajcn.111.016212; PMid:22170376

40. Timmermans S, Jaddoe VW, Hofman A et al. 2009. Periconception folic acid supplementation, fetal growth and the risks of low birth weight and preterm birth: the Generation R Study. Br. J. Nutr. 102;5:777–785. https://doi.org/10.1017/S0007114509288994; PMid:19327193

41. Bukowski R, Malone FD, Porter FT et al. 2009. Preconceptional folate supplementation and the risk of spontaneous preterm birth: a cohort study. PLoS Med. 6;5. ID 1000061.

42. Prinz-Langenohl R, Brдmswig S, Tobolski O et al. 2009. (6S)-5-methyltetrahydrofolate increases plasma folate more effectively than folic acid in women with the homozygous or wild-type 677C>T polymorphism of methylenetetrahydrofolate reductase. Br. J. Pharmacol. 158;8:2014–2021. https://doi.org/10.1111/j.1476-5381.2009.00492.x; PMid:19917061 PMCid:PMC2807663

43. Trabetti E. 2008. Homocysteine, MTHFR gene polymorphisms, and cardio-cerebrovascular risk. J. Appl. Genet. 49;3:267–282. https://doi.org/10.1007/BF03195624; PMid:18670064

44. Morris MS, Jacques PF, Rosenberg IH et al. 2010. Circulating unmetabolized folic acid and 5-methyltetrahydrofolate in relation to anemia, macrocytosis, and cognitive test performance in American seniors. Am. J. Clin. Nutr. 91;6:1733–1744. https://doi.org/10.3945/ajcn.2009.28671; PMid:20357042

45. Holm PI, Hustad S, Ueland PM et al. 2007. Modulation of the homocysteine-betaine relationship by methylenetetrahydrofolate reductase 677 C->t genotypes and B-vitamin status in a large-scale epidemiological study. J. Clin. Endocrinol. Metab. 92;4:1535–1541. https://doi.org/10.1210/jc.2006-1471; PMid:17284634

46. Gromova OA, Torshin IYu. 2010. Primenenie folievoy kislotyi v akushersko-ginekologicheskoy praktike: metodicheskie rekomendatsii. M.

47. Kim YI. 2007. Folate and colorectal cancer: an evidence-based critical review. Mol. Nutr. Food Res. 51;3:267–292. https://doi.org/10.1002/mnfr.200600191; PMid:17295418

48. Stolzenberg-Solomon RZ, Chang SC, Leitzmann MF et al. 2006. Folate intake, alcohol use, and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Am. J. Clin. Nutr. 83;4:895–904. PMid:16600944

49. Sauer J, Mason JB, Choi SW. 2009. Too much folate: a risk factor for cancer and cardiovascular disease? Curr. Opin. Clin. Nutr. Metab. Care. 12;1:30–36. https://doi.org/10.1097/MCO.0b013e32831cec62; PMid:19057184 PMCid:PMC2790187

50. Van Guelpen B. 2007. Folate in colorectal cancer, prostate cancer and cardiovascular disease. Scand. J. Clin. Lab. Invest. 67;5:459–473. https://doi.org/10.1080/00365510601161513; PMid:17763182

51. Pustotina OA, Ordzhonikidze NV, Butov YuS. 2002. Redkiy sluchay toksikodermii u beremennoy. Akusherstvo i ginekologiya 3:53–54.

52. Charles D, Ness AR, Campbell D et al. 2004. Taking folate in pregnancy and risk of maternal breast cancer. BMJ. 329;7479:1375–1376. https://doi.org/10.1136/bmj.329.7479.1375; PMid:15591563 PMCid:PMC535452

53. Prikaz Ministerstva zdravoohraneniya RF ot 12 noyabrya 2012 g. # 572n «Ob utverzhdenii Poryadka okazaniya meditsinskoy pomoschi po profilyu «akusherstvo i ginekologiya» (za isklyucheniem ispolzovaniya vspomogatelnyih reproduktivnyih tehnologiy» // www.rosminzdrav.ru/documents/5828-prikaz-minzdrava-rossii-ot-12-noyabrya-2012g-572n.

54. Lamers Y, Prinz-Langenohl R, Brдmswig S et al. 2006. Red blood cell folate concentrations increase more after supplementation with [6S]-5-methyltetrahydrofolate than with folic acid in women of childbearing age. Am. J. Clin. Nutr. 84;1:156–161. PMid:16825690

55. Heit JА, Kobbervig CE, James AH et al. 2005. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann. Intern. Med. 143;10:697–706.

56. Shehtman MM. 2011. Rukovodstvo po ekstragenitalnoy patologii u beremennyih. 5-e izd. M, Triada-H.